Mammoth Biosciences
Jeff Huber is a seasoned entrepreneur and investor with a strong background in deep tech, health tech, and the new economy. As Co-Founder and General Partner at Triatomic Capital since June 2022, Jeff focuses on applying AI to enable the creation of transformative businesses. Jeff serves on the Board of Directors for multiple companies, including Summit Therapeutics, Inc., d-Matrix, Manifold Bio, Zapata Computing, Inc., Upstart, Mammoth Biosciences, Openwater, and Genalyte, Inc., contributing expertise to pioneering advancements in areas such as cancer treatment, generative AI, CRISPR technology, and healthcare analytics. Jeff's extensive experience is complemented by over a decade of service on the Board of Directors at Electronic Arts, where involvement in various committees has supported the company's evolution in online and mobile platforms. Jeff holds a BS in Computer Engineering from the University of Illinois Urbana-Champaign and an MBA in Technology Strategy and Economics from Harvard Business School.
This person is not in the org chart
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.